Moleculin Biotech, Inc.
MBRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001659617
In the last 90 days, Moleculin Biotech, Inc. insiders filed 3 open-market purchases and 0 sales; 18 institutions reported holding it in 13F filings for Q2 2026, worth $518.5K in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Moleculin Biotech, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- 0 vs. Q1 2025
- Shares held
- 389.7K
- −1.09M (−73.6%) vs. Q1 2025
- Total value
- $117.9K
- −$1.32M (−91.8%) vs. Q1 2025
- New holders
- 4
- 7 more added
- Sold out
- 4
- 0 more reduced
1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $518.5K |
| Q1 2026 | 20 | $347.9K |
| Q4 2025 | 17 | $315.2K |
| Q3 2025 | 25 | $412.7K |
| Q2 2025 | 22 | $117.9K |
| Q1 2025 | 23 | $1.44M |
| Q4 2024 | 21 | $790.0K |
| Q3 2024 | 19 | $1.31M |
| Q2 2024 | 16 | $1.10M |
| Q1 2024 | 19 | $1.53M |
| Q4 2023 | 24 | $4.44M |
| Q3 2023 | 22 | $925.1K |
| Q2 2023 | 22 | $1.33M |
| Q1 2023 | 23 | $2.91M |
| Q4 2022 | 25 | $3.17M |
| Q3 2022 | 27 | $3.16M |
| Q2 2022 | 26 | $4.32M |
| Q1 2022 | 23 | $5.26M |
| Q4 2021 | 26 | $5.61M |
| Q3 2021 | 24 | $8.57M |
| Q2 2021 | 32 | $10.9M |
| Q1 2021 | 29 | $8.74M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Moleculin Biotech, Inc.; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Citigroup Inc | 85,283 | $25.7K | 0.00% | +82,495+2,958.9% | Added |
| XTX Topco Ltd | 74,217 | $22.4K | 0.00% | +62,642+541.2% | Added |
| Virtu Financial LLC | 59,278 | $18.0K | 0.00% | +59,278 | New |
| LPL Financial LLC | 56,080 | $16.9K | 0.00% | +10,000+21.7% | Added |
| Vanguard Group Inc | 30,935 | $9.34K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 27,530 | $8.31K | 0.00% | +1,473+5.7% | Added |
| Cambridge Investment Research Advisors, Inc. | 12,781 | $4.00K | 0.00% | 00.0% | Unchanged |
| BlackRock, Inc. | 12,380 | $3.74K | 0.00% | 00.0% | Unchanged |
| Truist Financial Corp | 10,500 | $3.17K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 7,989 | $2.41K | 0.00% | +7,989 | New |
| Tower Research Capital LLC (TRC) | 3,921 | $1.18K | 0.00% | +2,573+190.9% | Added |
| Stone House Investment Management, LLC | 3,300 | $996 | 0.00% | +3,300 | New |
| Newbridge Financial Services Group, Inc. | 2,867 | $866 | 0.00% | +1,500+109.7% | Added |
| Morgan Stanley | 926 | $280 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 746 | $225 | 0.00% | 00.0% | Unchanged |
| Atlantic Union Bankshares Corp | 379 | $115 | 0.00% | +379 | New |
| Bogart Wealth, LLC | 300 | $91 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 146 | $44 | 0.00% | +114+356.3% | Added |
| Advisor Group Holdings, Inc. | 43 | $12 | 0.00% | 00.0% | Unchanged |
| CVA Family Office, LLC | 34 | $10 | 0.00% | 00.0% | Unchanged |
| North Star Investment Management Corp. | 17 | $5 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,250,000−100.0% | Sold out |
| Cetera Investment Advisers | 0 | $0 | 0.00% | −70,000−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −344−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −34−100.0% | Sold out |
| Sandy Spring Bank | – | – | – | – | Not filed |